3Zelenetz A D, Hamlin P, Kewatramani T, et al. Ifosfamide, carboplatin, etoposicde ( ICE ) -based second-line chemotherapy for the management of relapsed and refractory aggressive non- Hodgkin lymphoma[J]. Ann Oncol, 2003, 14 (suppl 1):5-10.
4Chau I, Harfies M, Cunningham D, et al. Gemcitabine, cisplatin and methylprednisone chemotherapy (GEM-P) is on effective regimen in patients with poor prognostic progressive or multiply relapsed Hodgkin's and non-Hodgkin lymphoma[J]. Br J Heamatol, 2003, 120(6):970-977.
5Sarris A H, Phan A, Goy A, et al. Irinotecan in relapsed or refractory non-Hodgkin's lymphoma. Indications of activity in a phase Ⅱ trial[J].Oncology(Huntingt), 2002, 16(8 Suppl 7):27-31.
6Sugiyama K, Omachi K, Fujiwara K, et al. Irinoteacan hydro-chloride for the treatment of recurrent and refractory non - Hodgkin lymphoma[J]. Cancer, 2002, 94(13):594-600.
7Ribrag V, Koscielny S, Vantelon J M, et al. Phase trial of irinotecan(CPT11) in relapsed or refractory non - Hodgkin lymphoma[J]. Leuk Lmphoma, 2003, 44(9): 1529-1533.